Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia von Pan, Rongqing, Hogdal, Leah J, Benito, Juliana M, Bucci, Donna, Han, Lina, Borthakur, Gautam, Cortes, Jorge, DeAngelo, Daniel J, Debose, Lakeisha, Mu, Hong, Döhner, Hartmut, Gaidzik, Verena I, Galinsky, Ilene, Golfman, Leonard S, Haferlach, Torsten, Harutyunyan, Karine G, Hu, Jianhua, Leverson, Joel D, Marcucci, Guido, Müschen, Markus, Newman, Rachel, Park, Eugene, Ruvolo, Peter P, Ruvolo, Vivian, Ryan, Jeremy, Schindela, Sonja, Zweidler-McKay, Patrick, Stone, Richard M, Kantarjian, Hagop, Andreeff, Michael, Konopleva, Marina, Letai, Anthony G

Volltext

Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs von Miller, Claudia P., Manton, Christa A., Hale, Randal, DeBose, LaKeisha, Macherla, Venkat R., Potts, Barbara C., Palladino, Michael A., Chandra, Joya

Volltext

BCL-2-Selective BH3 Mimetic ABT-199 Is a Potent Agent For Acute Myeloid Leukemia von Pan, Rongqing, Debose, LaKeisha, Benito, Juliana M, Golfman, Leonard S, Zweidler-McKay, Patrick A, Han, Lina, Harutyunyan, Karine G., Mu, Hong, Ruvolo, Vivian R, Park, Eugene, Muschen, Markus, Leverson, Joel, Borthakur, Gautam, Kantarjian, Hagop M, Ruvolo, Peter P., Andreeff, Michael, Konopleva, Marina

Volltext